Form 4 for CDNA CareDx, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001217234-23-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | CDNA | Ronai Abraham | See Remarks | A - Grant | $0.00 | +85.1K | 160.8K | +112% | $0 |
| D | 2023-02-03 | 2023-02-01 | CDNA | Ronai Abraham | See Remarks | A - Grant | $0.00 | +44.1K | 44.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | A | A | 85,100 | $0.00 | 160,839 | D | — | — | (F1) The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter. |
| 2 | Derivative | Stock Option (right to buy) | 2023-02-01 | A | A | 44,100 | $0.00 | 44,100 | D | $15.66 · — to 2033-02-01 | 44,100 Common Stock | (F2) 1/4th of the shares subject to the option shall vest on February 2, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter. |